Skip to main content

CNL STRATEGIC CAPITAL ANNOUNCES OPERATING RESULTS FOR YEAR-END 2025

Orlando, Fla., March 27, 2026 (GLOBE NEWSWIRE) — CNL Strategic Capital, LLC (CNL Strategic Capital or the Company) seeks to provide current income and long-term appreciation to investors by acquiring controlling equity stakes in combination with loan positions in privately owned middle-market businesses. The Company announced its operating results for the year ended Dec. 31, 2025. Highlights:As of Dec. 31, 2025, CNL Strategic Capital’s portfolio consisted of equity and debt investments in 18 portfolio companies and had approximately $1.5 billion in total assets, compared with approximately $1.3 billion as of Dec. 31, 2024. For the year ended Dec. 31, 2025, the Company recognized a net change in unrealized appreciation on investments of approximately $113.6 million, including unrealized foreign currency gain and had total investment...

Continue reading

Monopar Reports Fourth Quarter and Full-Year 2025 Financial Results and Provides Business Update

WILMETTE, Ill., March 27, 2026 (GLOBE NEWSWIRE) — Monopar Therapeutics Inc. (“Monopar,” the “Company,” “we”) (Nasdaq: MNPR), a clinical-stage biopharmaceutical company developing innovative treatments for patients with unmet medical needs, today announced the fourth quarter and full-year 2025 financial results and provided a summary of recent developments. “2025 was a productive year for Monopar, marked by multiple ALXN1840 data presentations, an important publication, a strengthened balance sheet and continued progress toward a planned New Drug Application submission for ALXN1840 in Wilson disease,” said Chandler Robinson, MD, Chief Executive Officer of Monopar. “We also recently strengthened our leadership team with the addition of Susan Rodriguez as Chief Commercial and Strategy Officer as we prepare for the potential launch...

Continue reading

Sword Group : Availability of the 2025 Financial Report

According to the current regulations, Sword Group announces that its 2025 Financial Report has been made available to the public.It was sent to the Commission de Surveillance du Secteur Financier (CSSF) and was also filed with the Luxembourg Stock Exchange.It can be viewed and downloaded on the website of the company: 2025 FINANCIAL REPORT About Sword GroupSword has 3,600+ IT/Digital specialists active in 50+ countries to accompany you in the growth of your organisation in the digital age.As a leader in technological and digital transformation, Sword has a solid reputation in complex IT & business project management.Sword optimises your processes and enhances your data.AttachmentSwordGroup_Availability of the 2025 Financial Report_V27032026

Continue reading

EUROAPI – Availability of the 2025 Universal Registration Document

  Press Release     Availability of the 2025 Universal Registration Document, including the Annual Financial Report Paris – March 27, 2026 – EUROAPI announces the publication of its 2025 Universal Registration Document in ESEF format, filed with the French Autorité des marchés financiers (AMF) on March 27, 2026. The 2025 Universal Registration Document contains in particular:The annual financial report, including the management report that encompasses namely the Corporate Governance report, the sustainability statement and the company and consolidated statements; The statutory auditors’ reports, including the special report on the regulated agreements; The disclosures relating to statutory auditors’ fees; and The disclosures relating to the description of the share buy-back program.This document is available on EUROAPI’s website:...

Continue reading

LECTRA: availability of 2025 Annual Financial Report

 Lectra: availability of 2025 Annual Financial Report Paris, March 27, 2026 – Lectra announces that its 2025 Annual Financial Report has been released and filed with the French Financial Markets Authority (Autorité des marchés financiers). The 2025 Annual Financial Report containing the Parent company and consolidated financial statements, the Management Report, the Corporate Governance Report and the Sustainability Report is now available in the ESEF format (European Single Electronic Format) and in PDF version on the company’s website: https://www.lectra.com/fr/investisseurs/information-financiere/publications. An English version of the Annual Financial Report 2025 is also available on the company’s website: https://www.lectra.com/en/investors/financial-information/publications. About LectraAt the forefront of innovation...

Continue reading

United-Guardian Reports 2025 Financial Results

HAUPPAUGE, N.Y., March 27, 2026 (GLOBE NEWSWIRE) — United-Guardian, Inc. (NASDAQ:UG) reported that net sales and net income for FY 2025 decreased compared to FY 2024. Net sales for the year decreased by 13% from $12,181,971 in 2024 to $10,545,468 in 2025, generating net income of $3,250,875 ($0.71 per share) in 2024 compared to $2,105,738 ($0.46 per share) in 2025. Donna Vigilante, President of United-Guardian, stated, “Our financial performance in 2025 was primarily impacted by the decrease in sales of our cosmetic ingredients. One of the issues we faced was excess inventory held by our largest cosmetic ingredient distributor, Ashland Specialty Ingredients (“ASI”). The inventory overstock led to reduced order quantities from ASI throughout the year. The situation was further impacted by decreased global demand for our products,...

Continue reading

Quantum Biopharma’s 2025 Audited Year End Financial Results Maintain ‘No Going Concern’ Status

Financial Statements as of Date of Filing Show Strong Improvements in Cash, Reduction in Accounts Payable, and a Cash Runway Through January 2028 Multiple Sclerosis Drug Candidate Lucid-21-302 Phase 1 Trial with Toxicology Studies Complete, and unbuzzd™ Clinical Trial Published in Peer-Reviewed Journal TORONTO, March 27, 2026 (GLOBE NEWSWIRE) — Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) (FRA: 0K91) (“Quantum” or the “Company”), has reported its audited financial and operational results for the fourth quarter and year ended December 31, 2025. Fourth Quarter and Full Year 2025 Financial Results Quantum’s strong balance sheet and overall progress continue, and management is confident that there is sufficient working capital, as of the date of filing these Financial Statements, to carry out its operations over the next...

Continue reading

TMC Announces Fourth Quarter and Full Year 2025 Results

NEW YORK, March 27, 2026 (GLOBE NEWSWIRE) — TMC the metals company Inc. (Nasdaq: TMC) (“TMC” or “the Company”), a leading developer of the world’s largest resource of critical metals essential to energy, defense, manufacturing and infrastructure, today provided a corporate update and fourth quarter and full year financial results for the period ending December 31, 2025. Fourth Quarter and Full Year 2025 Financial HighlightsTotal cash of approximately $117.6 million at December 31, 2025 $11.4 million cash used in operations for the quarter ended December 31, 2025 Operating loss of $44.7 million, net loss of $40.4 million and net loss per share of $0.08 for the quarter ended December 31, 2025Exclusive Negotiations Underway for Nodule Processing & Refining Hub in Brownsville, TexasExclusive negotiations for 1,466 acres with...

Continue reading

Hydrofarm Holdings Group Announces Fourth Quarter and Full Year 2025 Results

SHOEMAKERSVILLE, Pa., March 27, 2026 (GLOBE NEWSWIRE) — Hydrofarm Holdings Group, Inc. (“Hydrofarm” or the “Company”) (Nasdaq: HYFM), a leading independent manufacturer and distributor of branded hydroponics equipment and supplies for controlled environment agriculture, today announced financial results for its fourth quarter and fiscal year ended December 31, 2025. Fourth Quarter vs. Prior Year Period:Net sales decreased to $25.1 million compared to $37.3 million. Gross Profit Margin increased to 8.5% of net sales compared to 4.9%. Adjusted Gross Profit Margin(1) increased to 15.4% of net sales compared to 9.6%. SG&A expense and Adjusted SG&A(1) expense decreased by 43.5% and 18.9%, respectively. Net loss increased to $242.2 million compared to $17.5 million. Net loss in the fourth quarter of 2025 included a non-cash...

Continue reading

BTCS Reports 305% Year-Over-Year Revenue Growth to Record $16.5 Million for Full Year 2025

Revenue growth driven by expanding Builder+ block-building activity, with Imperium delivering $1.3 million in revenue following its Q3’25 launch WAYNE, Pa., March 27, 2026 (GLOBE NEWSWIRE) — BTCS Inc. (Nasdaq: BTCS) (“BTCS” or the “Company”), short for Blockchain Technology Consensus Solutions, a company focused on blockchain infrastructure and decentralized finance operations, today announced its financial results for the year ended December 31, 2025 (“FY 2025”). The Company also released an updated investor presentation available at www.btcs.com/investors/. “2025 was a transformative year for BTCS as we scaled our Ethereum-first operating model and delivered record revenue,” said Charles Allen, Chief Executive Officer of BTCS. “Revenue grew over 300%, driven by the expansion of Builder+, our block-building business, and the successful...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.